SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences surges on receiving EUGMP certification for formulation facility at Ankleshwar

06 Apr 2016 Evaluate

RPG Life Sciences is currently trading at Rs. 257.80, up by 24.30 points or 10.41% from its previous closing of Rs. 233.50 on the BSE.

The scrip opened at Rs. 253.00 and has touched a high and low of Rs. 259.90 and Rs. 246.60 respectively. So far 73,000 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 8 has touched a 52 week high of Rs. 360.60 on 03-Dec-2015 and a 52 week low of Rs. 130.50 on 24-Apr-2015.

Last one week high and low of the scrip stood at Rs. 259.90 and Rs. 221.00 respectively. The current market cap of the company is Rs. 426.47 crore.

The promoters holding in the company stood at 66.79% while Institutions and Non-Institutions held 0.28% and 32.93% respectively.

RPG Life Sciences has received GMP certification from Bavarian Authority, a competent authority in Germany, as per EUGMP standards for its formulation facility at Ankleshwar in Gujarat. The Bavarian authority conducted the audit of the manufacturing facility in early March 2016.The certification will help the company in boosting sales by expanding its geographical presence in the European markets.

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.


RPG Life Sciences Share Price

2025.85 126.05 (6.63%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×